91
Views
19
CrossRef citations to date
0
Altmetric
Review

Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy

Pages 165-173 | Published online: 05 May 2015

References

  • BleiATCórdobaJPractice Parameters Committee of the American College of GastroenterologyHepatic encephalopathyAm J Gastroenterol20019671968197611467622
  • VilstrupHAmodioPBajajJHepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the LiverHepatology201460271573525042402
  • LeiseMDPoteruchaJJKamathPSKimWRManagement of hepatic encephalopathy in the hospitalMayo Clin Proc201489224125324411831
  • AmodioPDel PiccoloFPettenòEPrevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patientsJ Hepatol2001351374511495040
  • BustamanteJRimolaAVenturaPJPrognostic significance of hepatic encephalopathy in patients with cirrhosisJ Hepatol199930589089510365817
  • FichetJMercierEGenéeOPrognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathyJ Crit Care200924336437019327960
  • WongRJGishRGAhmedAHepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantationLiver Transpl201420121454146125155379
  • KimWRKamathPSShahNUtilization and outcome of critical care in patients with cirrhosis in the USHepatology201052S1910A911A
  • NeffGWKemmerNDuncanCAlsinaAUpdate on the management of cirrhosis – focus on cost-effective preventative strategiesClinicoecon Outcomes Res2013514315223626470
  • ChackoKRSigalSHUpdate on management of patients with overt hepatic encephalopathyHosp Pract (1995)2013413485923948621
  • StepanovaMMishraAVenkatesanCYounossiZMIn-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009Clin Gastroenterol Hepatol20121091034104122642955
  • PoordadFFReview article: the burden of hepatic encephalopathyAliment Pharmacol Ther200725Suppl 13917295846
  • NeffGPharmacoeconomics of hepatic encephalopathyPharmacotherapy2010305 Pt 228S32S20412038
  • NeffGWBarrettACGrahamCMGayleJErnstFRHospital costs, length of stay, and readmission rates in a cohort of cirrhotic patients discharged with hepatic encephalopathyHepatology201358S1390A391A
  • VolkMLToccoRSBazickJRakoskiMOLokASHospital readmis-sions among patients with decompensated cirrhosisAm J Gastroenterol2012107224725221931378
  • ArguedasMRDeLawrenceTGMcGuireBMInfluence of hepatic encephalopathy on health-related quality of life in patients with cirrhosisDig Dis Sci20034881622162612924658
  • BajajJSSchubertCMHeumanDMPersistence of cognitive impairment after resolution of overt hepatic encephalopathyGastroenterology201013872332234020178797
  • HuangEEsrailianESpiegelBMThe cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysisAliment Pharmacol Ther20072681147116117894657
  • MontagneseSAmatoESchiffSA patients’ and caregivers’ perspective on hepatic encephalopathyMetab Brain Dis201227456757222791269
  • OnyekwereCAOgberaAOHameedLChronic liver disease and hepatic encephalopathy: clinical profile and outcomesNiger J Clin Pract201114218118521860136
  • UdayakumarNSubramaniamKUmashankarLVergheseJJayanthiVPredictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observationJ Clin Gastroenterol2007411092292618090162
  • VolkMLToccoRSBazickJRakoskiMOLokASHospital readmissions among patients with decompensated cirrhosisAm J Gastroenterol2012107224725221931378
  • ConglySELeiseMDKimWRCost effectiveness of rifaximin in the treatment of hepatic encephalopathyHepatology201358S1869A
  • MasadehMMGonzalez-FragaJDAl-afghaniAHCompliance with process of care among patients hospitalized with liver cirrhosisGastroenterology20141465 Suppl 1S-986
  • MasadehMMHussainFSprattHSonsteinLEl HaijaMASolowayRDA novel model to predict the likelihood of readmission within 30 days in patients hospitalized with liver cirrhosisGastroenterology20141465 Suppl 1S-986
  • NeffGWKemmerNParkinsonEFallonECAlsinaAHospital readmissions metrics (HRM) related to hepatic encephalopathy (HE)Hepatology201358S1890A891A23505208
  • DhimanRKRanaBAgrawalSProbiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trialGastroenterology201414761327133725450083
  • PatidarKRThackerLRWadeJBCovert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalizationAm J Gastroenterol2014109111757176325178701
  • NeffGWFrederickRTAssessing treatment patterns in patients with overt hepatic encephalopathyHepatology201256Suppl 1945A
  • BajajJSSchubertCMHeumanDMPersistence of cognitive impairment after resolution of overt hepatic encephalopathyGastroenterology201013872332234020178797
  • SotilEUGottsteinJAyalaERandolphCBleiATImpact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantationLiver Transpl200915218419219177446